APOLLO HOSPITALS ENTER. L (508869) — Latest Corporate Announcements
₹7,817.5
+₹42.50 (+0.55%)
Market Cap
₹1,12,403.65 Cr
P/E Ratio
53.82
52W Range
₹6696.5 – ₹9070.5
Board Meeting Intimations
📅 Scheduled Board Meeting & Agenda
Meeting Date: 04-Nov-2026
Agenda / Purpose: Financial Results/Other business matters
Timeline: In 22 days
Corporate Actions & Regulatory Filings
To consider and approve the financial results for the period ended September 30, 2026 and other business matters
Apollo Hospitals Enterprise Ltd - 508869 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Apollo Hospitals Enterprise Ltd - 508869 - Closure of Trading Window
Apollo Hospitals Enterprise Ltd - 508869 - Summary Of Proceedings Of AGM And Voting Results
To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters
To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters
To consider and approve the financial results for the period ended December 31, 2025, dividend and other business matters
To consider and approve the financial results for the period ended September 30, 2025 and other business matters
To consider and approve the financial results for the period ended Jun 30, 2025 and other business matters
To consider and approve the financial results for the period ended March 31, 2025, dividend and other business matters
To consider and approve the financial results for the period ended December 31, 2024 and other business matters
To consider and approve the financial results for the period ended September 30, 2024 and other business matters
To consider and approve the financial results for the period ended Jun 30, 2024 and other business matters
To consider and approve the financial results for the period ended March 31, 2024, dividend and other business matters
To consider and approve the financial results for the period ended December 31, 2023 and other business matters
To consider and approve the financial results for the period ended September 30, 2023 and other business matters
To consider and approve the financial results for the period ended Jun 30, 2023 and other business matters
To consider and approve the financial results for the period ended March 31, 2023, dividend and other business matters
To consider and approve the financial results for the period ended December 31, 2021 and other business matters
To consider and approve the financial results for the period ended September 30, 2021 and other business matters
Financial Results (Quarterly & Annual)
| Quarter / Period | Meeting / Outcome Date | Status | Filing Details |
|---|---|---|---|
| Quarter Ended 30-Sep-2026 (Q2 FY27) | 04-Nov-2026 | Scheduled Upcoming | To consider and approve the financial results for the period ended September 30, 2026 and other business matters |
| Quarter Ended 30-Jun-2026 (Q1 FY27) | 12-Aug-2026 | Declared | To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters |
| Year Ended 31-Mar-2026 (Q4 FY26) | 20-May-2026 | Declared | To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters |
| Quarter Ended 31-Dec-2025 (Q3 FY26) | 10-Feb-2026 | Declared | To consider and approve the financial results for the period ended December 31, 2025, dividend and other business matters |
| Quarter Ended 30-Sep-2025 (Q2 FY26) | 06-Nov-2025 | Declared | To consider and approve the financial results for the period ended September 30, 2025 and other business matters |
| Quarter Ended 30-Jun-2025 (Q1 FY26) | 12-Aug-2025 | Declared | To consider and approve the financial results for the period ended Jun 30, 2025 and other business matters |
| Year Ended 31-Mar-2025 (Q4 FY25) | 30-May-2025 | Declared | To consider and approve the financial results for the period ended March 31, 2025, dividend and other business matters |
| Quarter Ended 31-Dec-2024 (Q3 FY25) | 10-Feb-2025 | Declared | To consider and approve the financial results for the period ended December 31, 2024 and other business matters |
| Quarter Ended 30-Sep-2024 (Q2 FY25) | 06-Nov-2024 | Declared | To consider and approve the financial results for the period ended September 30, 2024 and other business matters |
| Quarter Ended 30-Jun-2024 (Q1 FY25) | 13-Aug-2024 | Declared | To consider and approve the financial results for the period ended Jun 30, 2024 and other business matters |
| Year Ended 31-Mar-2024 (Q4 FY24) | 30-May-2024 | Declared | To consider and approve the financial results for the period ended March 31, 2024, dividend and other business matters |
| Quarter Ended 31-Dec-2023 (Q3 FY24) | 08-Feb-2024 | Declared | To consider and approve the financial results for the period ended December 31, 2023 and other business matters |
Track Related Peer Equities
Related Research Guides & Regulatory Playbooks
Frequently Asked Questions about APOLLO HOSPITALS ENTER. L BSE Disclosures
What is the latest BSE announcement by APOLLO HOSPITALS ENTER. L?
The latest BSE disclosure by APOLLO HOSPITALS ENTER. L (APOLLOHOSP), filed on 04-Nov-2026 , is: "To consider and approve the financial results for the period ended September 30, 2026 and other business matters". Bsenexus tracks every official filing for APOLLO HOSPITALS ENTER. L with AI-powered summaries on its announcements feed.
When is APOLLO HOSPITALS ENTER. L's next board meeting?
APOLLO HOSPITALS ENTER. L has a board meeting scheduled for 04-Nov-2026 (in 22 days) to consider: Financial Results/Other business matters.
When does APOLLO HOSPITALS ENTER. L declare quarterly results?
Under SEBI (LODR) Regulation 33, listed companies submit quarterly unaudited results within 45 days of the quarter ending, and annual audited figures within 60 days. APOLLO HOSPITALS ENTER. L's recent results history is tabulated above. Track scheduled board meetings on the Bsenexus Results Calendar.